JPET Introducing ALZET?ew Model 2006 Pump

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Creese, H.
Right arrow Articles by Taylor, D. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Creese, H.
Right arrow Articles by Taylor, D. B.
Journal of Pharmacology And Experimental Therapeutics, Vol. 157, Issue 2, 406-419, 1967
Copyright © 1967 by American Society for Pharmacology and Experimental Therapeutics


ENTRY OF LABELED CARBACHOL IN BRAIN SLICES OF THE RAT AND THE ACTION OF d-TUBOCURARINE AND STRYCHNINE

H. Creese 1 and D. B. Taylor 1

1 Department of Pharmacology and Brain Research Institute. UCLA School of Medicine, Los Angeles, California

Slides of cerebral cortex, cereheilar cortex and gray matter of time spinal cord of rats concentrated carhachol wimicim had been labeled with tritium, and the uptake was largely inhibited by d-tubocurarine and by strychnine. White matter showed little accumulation. Carbachol up to 0.8 M produced no detectable loss of potassium in slices of cerebral cortex, and at low doses the carbachol became concentrated until the ratio between tissue and saline approached that of Potassium. In the absence of glucose there was a fall in potassium content and a low uptake of carhachol, and with high external potassium the tissues were unable to concentrate either potassium or carbachol. With increased concentrations of carbachol time accumulation of the drug showed saturation, and the movements of carbachol were consistent with a monovalent carrier mechanism having a half-saturation constant of 41 µM and a capacity of 156 x 10-9 mol/g/hr. The saturable and curare-sensitive components of entry were similar, and the saturable entry of carhachol was inhibited by d-tubocurarine with an inhibitory constant of 3 µM. The effect of d-tubocurarine in slowing the influx of labeled carbachol could he described by time same procedures as those used in time case of pharmacologic antagonism, and the dose-effect curve and Gaddum's equation for equinctive doses were found to apply to the inward movements of carbachol.

Submitted on September 12, 1966
Accepted on March 16, 1967







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1967 by the American Society for Pharmacology and Experimental Therapeutics.